These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39130482)

  • 1. Trifolirhizin protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption.
    Lin Z; Zhou Z; Ye J; Wei J; Chen S; Zhou W; Bi Y; Zhou Z; Xie G; Yuan G; Yao G
    Heliyon; 2024 Jul; 10(14):e34250. PubMed ID: 39130482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca
    Zou B; Zheng J; Deng W; Tan Y; Jie L; Qu Y; Yang Q; Ke M; Ding Z; Chen Y; Yu Q; Li X
    Phytomedicine; 2021 Jan; 80():153377. PubMed ID: 33126167
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Han SY; Kim JH; Jo EH; Kim YK
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33810474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis.
    Lin X; Xu F; Zhang KW; Qiu WX; Zhang H; Hao Q; Li M; Deng XN; Tian Y; Chen ZH; Qian AR
    Front Cell Dev Biol; 2022; 10():796227. PubMed ID: 35517504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss.
    Ma L; Zhang L; Liao Z; Xiu C; Luo X; Luo N; Zhang L; He G; Chen J
    J Orthop Translat; 2023 Sep; 42():1-14. PubMed ID: 37521493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss.
    Shi L; Ren L; Li J; Liu X; Lu J; Jia L; Xie B; Tang S; Liu W; Zhang J
    Chin J Nat Med; 2024 Mar; 22(3):212-223. PubMed ID: 38553189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species.
    Hong G; Chen Z; Han X; Zhou L; Pang F; Wu R; Shen Y; He X; Hong Z; Li Z; He W; Wei Q
    Clin Transl Med; 2021 May; 11(5):e392. PubMed ID: 34047464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.
    Qiu Z; Li L; Huang Y; Shi K; Zhang L; Huang C; Liang J; Zeng Q; Wang J; He X; Qin L; Wang X
    J Orthop Translat; 2022 Mar; 33():55-69. PubMed ID: 35228997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway.
    Wu L; Liang J; Li J; Xu Y; Chen J; Su Y; Xian Y; Wei J; Xu J; Zhao J; Liu Q; Yang Y
    Eur J Pharmacol; 2022 May; 923():174908. PubMed ID: 35405113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss.
    Sun X; Zhang C; Guo H; Chen J; Tao Y; Wang F; Lin X; Liu Q; Su L; Qin A
    Front Pharmacol; 2020; 11():360. PubMed ID: 32292342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss.
    Han SY; Kim YK
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
    Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
    Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
    [No Abstract]   [Full Text] [Related]  

  • 14. Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
    Tian K; Su Y; Ding J; Wang D; Zhan Y; Li Y; Liang J; Lin X; Song F; Wang Z; Xu J; Liu Q; Zhao J
    Life Sci; 2020 Mar; 244():117336. PubMed ID: 31972206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anethole inhibits RANKL-induced osteoclastogenesis by downregulating ERK/AKT signaling and prevents ovariectomy-induced bone loss in vivo.
    Qu H; Zhang Y; He R; Lin N; Wang C
    Int Immunopharmacol; 2021 Nov; 100():108113. PubMed ID: 34530203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
    Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F
    Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of a prominent dihydroxyflavanone pinocembrin for osteolytic bone disease:
    Hong G; Li S; Zheng G; Zheng X; Zhan Q; Zhou L; Wei Q; He W; Chen Z
    J Orthop Translat; 2024 Mar; 45():197-210. PubMed ID: 38685969
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lee J; Ahn SH; Chen Z; Kang S; Choi DK; Moon C; Min SH; Park BJ; Lee TH
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidementia medication acetylcholinesterase inhibitors have therapeutic benefits on osteoporotic bone by attenuating osteoclastogenesis and bone resorption.
    Li S; Teguh D; Wu D; Liu L; Hu C; Yuan J; Inderjeeth CA; Xu J
    J Cell Physiol; 2023 Aug; 238(8):1823-1835. PubMed ID: 37334837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.